$78.5 Million is the total value of EDBI Pte Ltd's 19 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -3,181 | -100.0% | -0.01% | – |
| BILL | Exit | BILL COM HLDGS INC | $0 | – | -296 | -100.0% | -0.04% | – |
| ALXO | Exit | ALX ONCOLOGY HLDGS INC | $0 | – | -5,613 | -100.0% | -0.06% | – |
| NRIX | Exit | NURIX THERAPEUTICS INC | $0 | – | -7,442 | -100.0% | -0.10% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -7,484 | -100.0% | -0.18% | – |
| Exit | HASHICORP INC | $0 | – | -6,500 | -100.0% | -0.22% | – | |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -55,855 | -100.0% | -1.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-01-30
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JOBY AVIATION INC | 8 | Q3 2023 | 37.2% |
| SNOWFLAKE INC | 8 | Q3 2023 | 22.7% |
| SPRINKLR INC | 8 | Q3 2023 | 16.6% |
| GRAB HOLDINGS LIMITED | 8 | Q3 2023 | 11.6% |
| WALKME LTD | 8 | Q3 2023 | 10.8% |
| ERASCA INC | 8 | Q3 2023 | 7.5% |
| PLANET LABS PBC | 8 | Q3 2023 | 6.1% |
| NUVATION BIO INC | 8 | Q3 2023 | 5.9% |
| AVEPOINT INC | 8 | Q3 2023 | 5.1% |
| I-MAB | 8 | Q3 2023 | 5.7% |
View EDBI Pte Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-18 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-01-30 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-02-25 |
View EDBI Pte Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.